Literature DB >> 8033809

Gene expression of pancreatic-type phospholipase-A2 in rat ovaries: stimulatory action on progesterone release.

K Nomura1, H Fujita, H Arita.   

Abstract

We reported previously that pancreatic-type group I phospholipase-A2 (PLA2-I) stimulates DNA synthesis or prostaglandin E2 production in various cell types via its specific receptors on the cell surface. In the present study we examined the effect of PLA2-I on corpus luteum, which possesses specific PLA2-I receptors, and demonstrated gene expression of PLA2-I in rat ovaries. PLA2-I stimulated progesterone release from incubated corpora lutea at concentrations above 10 nM in a dose-dependent manner. Northern blot analysis revealed the presence of PLA2-I messenger RNA (mRNA) in rat ovaries. The level of PLA2-I mRNA was elevated during diestrus to proestrus, and decreased to almost nothing on the day of estrus. To further evaluate the timing of PLA2-I expression, we analyzed RNAs extracted from small follicles, large preovulatory follicles, and corpora lutea obtained from various phases of hCG-treated immature rats. During follicular development, mRNA levels remained negligible. The level of PLA2-I mRNA began to rise after luteinization of follicles and increased during the maturation of the corpora lutea. Levels of PLA2-I mRNA in ovaries from day 5 and day 10 pregnant rats were 5- to 10-fold higher than those in diestrous rats, whereas on day 21, the mRNA level was decreased. Immunocytochemical studies were performed to clarify the synthesis and localization of PLA2-I in the ovary using polyclonal anti-PLA2-I antibodies. Intense immunoreactivity was detected only in luteal cells of newly formed corpora lutea. However, the number and intensity of immunoreactive cells decreased in old corpora lutea. No immunoreactivity was detected in follicular cells of small- or middle-sized follicles. These results demonstrate the correlation among PLA2-I gene expression, estrous cycle, and progesterone secretion in rat ovaries and suggest a new function of PLA2-I as an intragonadal regulatory factor for steroidogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033809     DOI: 10.1210/endo.135.2.8033809

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Increased activity of group II phospholipase A2 in plasma in rat sodium deoxycholate induced acute pancreatitis.

Authors:  S Furue; Y Hori; K Kuwabara; J Ikeuchi; H Onoyama; M Yamamoto; K Tanaka
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

2.  Phospholipase A2 isoforms are altered in chronic pancreatitis.

Authors:  M Kashiwagi; H Friess; W Uhl; H Graber; R Duarte; A Zimmermann; M W Büchler
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

3.  Helicobacter infection and phospholipase A2 enzymes: effect of Helicobacter felis-infection on the expression and activity of sPLA2 enzymes in mouse stomach.

Authors:  A Ottlecz; J J Romero; L M Lichtenberger
Journal:  Mol Cell Biochem       Date:  2001-05       Impact factor: 3.396

4.  Group II and IV phospholipase A(2) are produced in human pancreatic cancer cells and influence prognosis.

Authors:  M Kashiwagi; H Friess; W Uhl; P Berberat; M Abou-Shady; M Martignoni; S E Anghelacopoulos; A Zimmermann; M W Büchler
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

5.  Phospholipase A2 isoforms in acute pancreatitis.

Authors:  H Friess; S Shrikhande; E Riesle; M Kashiwagi; K Baczako; A Zimmermann; W Uhl; M W Büchler
Journal:  Ann Surg       Date:  2001-02       Impact factor: 12.969

6.  Group IVA phospholipase A₂ optimizes ovulation and fertilization in rodents through induction of and metabolic coupling with prostaglandin endoperoxide synthase 2.

Authors:  Shiro Kurusu; Adam Sapirstein; Joseph V Bonventre
Journal:  FASEB J       Date:  2012-06-06       Impact factor: 5.191

Review 7.  Secreted Phospholipases A2 - not just Enzymes: Revisited.

Authors:  Adrijan Ivanušec; Jernej Šribar; Igor Križaj
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.